Key facts
- This page summarizes Jack J. Tobin's Form 4 filing for CME GROUP INC. (CME).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 17 Mar 2026, 12:23.
Jack J. Tobin - 15 Mar 2026 Form 4 Insider Report for CME GROUP INC. (CME)
- Reporting relationship
- MD Chief Accounting Officer
- Issuer ticker
- CME
- Reported as of
- 15 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Mar 2026, 12:23:17 UTC
- Prior SEC filing
- 12 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- By: Margaret Austin Wright for Jack J. Tobin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jack J. Tobin filed Form 4 for CME GROUP INC. (CME) on 17 Mar 2026.
Change
- Previous filing in this sequence was filed on 12 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001638430
Primary reporting owner
Tobin Jack J
- Relationship
- MD Chief Accounting Officer
- Address
- 20 S. WACKER DRIVE, CHICAGO
- Signature
- By: Margaret Austin Wright for Jack J. Tobin
- Signature date
- 17 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CME
transaction
Common Stock Class A
Award
- Transaction value
- Shares
- +608
- Change %
- +2.4%
- Price
- $311.40*
- Shares after
- 25,588
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
CME
transaction
Common Stock Class A
Tax liability
- Transaction value
- Shares
- -179
- Change %
- -0.7%
- Price
- $311.40*
- Shares after
- 25,409
- Date
- 15 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
Footnote F2
Mr. Tobin surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.